Page last updated: 2024-10-22

albuterol and Precursor Cell Lymphoblastic Leukemia-Lymphoma

albuterol has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 1 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Precursor Cell Lymphoblastic Leukemia-Lymphoma: A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Russell, L1
Shaw, NJ1
Eden, OB1

Other Studies

1 other study available for albuterol and Precursor Cell Lymphoblastic Leukemia-Lymphoma

ArticleYear
Efficacy of salbutamol in chronic cough in childhood leukaemia.
    Lancet (London, England), 1989, Mar-04, Volume: 1, Issue:8636

    Topics: Albuterol; Child; Chronic Disease; Cough; Drug Evaluation; Humans; Pilot Projects; Precursor Cell Ly

1989